Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Global Stock · Morgan Stanley

Global Endurance Portfolio Class R6 (MSJSX)

Ticker MSJSX · · Holdings as of Jun 30, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
−3.3%annualized
1-yr return
+24.7%as of Dec 2025
Net assets
$16.2Mall share classes
Holdings
31

Bottom line

Is MSJSX a good fund? The bottom line

MSJSX is the Class R6 share class of Global Endurance Portfolio, an actively managed global stock mutual fund from Morgan Stanley.

Annual fees run 0.95% — about $95 a year on every $10,000 invested, more expensive than 51% of global stock funds we track.

It returned +24.7% over one year, −3.3% a year over five years (as of Dec 31, 2025, per its prospectus).

With $16.2 million in net assets and 31 holdings, its largest position is Victoria PLC (19.0%) and the top 10 make up 61.6% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 61.6% of assets
  • Small fund ($16.2 million) — small funds are likelier to close
  • High turnover (176% a year) can mean more taxable distributions

Updated Nov 19, 2026

What MSJSX invests in

The Global Endurance Portfolio (the Fund) seeks long-term capital appreciation.

Under normal market conditions, the Adviser seeks to achieve the Funds investment objective by investing primarily in equity securities of established and emerging companies located throughout the world, with capitalizations within the range of companies included in the MSCI All Country World Index. The Adviser emphasizes a bottom-up stock selection process, seeking attractive investments on an individual company basis. In selecting securities for investment, the Adviser seeks to invest in companies with strong name recognition and sustainable competitive advantages. The Adviser typically favors companies with rising returns on invested capital, above-average business visibility, strong free cash flow generation and an attractive risk/reward. The Adviser typically focuses a significant portion of the Funds investments in a limited number of issuers, which may be in the same industry…

From the fund's prospectus (filed Apr 30, 2026).

MSJSX performance

Average annual total returns
1 yr5 yr10 yr
MSJSX+24.7%−3.3%—
Global Stock median+15.2%+7.6%+9.5%

Source: Fund prospectus, as of Dec 31, 2025

Full MSJSX performance history →

What MSJSX costs

On a $10,000 investment, MSJSX's 0.95% expense ratio costs about $95 a year. The prospectus estimates $7,045 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.

See the full MSJSX fee table →

MSJSX top 10 holdings

#Holding% of fund
1Victoria PLC19.05%
2Roivant Sciences Ltd7.26%
3Arbutus Biopharma Corp5.50%
4Immunovant Inc4.86%
5QXO Inc4.84%
6Floor & Decor Holdings Inc4.83%
7Teleflex Inc4.11%
8Royalty Pharma PLC3.82%
9DraftKings Inc3.70%
10Calumet Inc3.63%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 61.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSJSX

More funds like MSJSX →

MSJSX FAQ

What is the expense ratio of MSJSX?
MSJSX's expense ratio is 0.95%, which works out to about $95 a year for every $10,000 invested. The prospectus estimates total costs of $7,045 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSJSX a good investment?
It depends on your goals, but the data points to: no front-end sales load; 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 61.6% of assets; small fund ($16.2 million) — small funds are likelier to close; high turnover (176% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does MSJSX hold?
MSJSX's largest holdings are Victoria PLC (19.0%), Roivant Sciences Ltd (7.3%), Arbutus Biopharma Corp (5.5%), Immunovant Inc (4.9%), QXO Inc (4.8%). It holds 31 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MSJSX's 5-year return?
MSJSX returned −3.3% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does MSJSX have a sales load?
No. MSJSX has no front-end sales charge.
Who manages MSJSX?
MSJSX is offered by Morgan Stanley through Morgan Stanley Institutional Fund Inc.